Systemic Treatments for Allergic Contact Dermatitis.

Area of Science:

• Immunology
• Dermatology

Background:

• Allergic contact dermatitis (ACD) is a common delayed-type hypersensitivity reaction.
• Severe ACD cases often require systemic therapies beyond topical steroids.
• Current systemic treatments like cyclosporine pose challenges upon withdrawal due to potential morbidities.

Purpose of the Study:

• To review systemic treatment targets for widespread, recalcitrant allergic contact dermatitis.
• To discuss currently used off-label systemic medications for severe ACD.
• To explore potential future therapeutics for recalcitrant ACD.

Main Methods:

• Literature review of existing and emerging systemic treatments for allergic contact dermatitis.
• Analysis of therapeutic targets for off-label systemic medications.
• Identification of novel drug candidates in the pipeline for recalcitrant ACD.

Main Results:

• Topical steroids are often insufficient for severe allergic contact dermatitis.
• Systemic therapies, while effective, present challenges with drug withdrawal.
• No specific systemic treatments are currently indicated for widespread, recalcitrant ACD.

Conclusions:

• There is a significant unmet need for indicated systemic treatments for widespread recalcitrant allergic contact dermatitis.
• Understanding targets of off-label systemic drugs is crucial.
• Investigating novel therapeutics in the pipeline is essential for managing severe ACD.